Intratracheal transplantation of iPSC-AEC2 is able to reduce pulmonary fibrosis when fibrosis has already developed, decreasing the amount of collagen by the inhibition of both TGF-β and α-SMA expression. Here, ACTA1 is linked to pulmonary fibrosis.